Thomas Wierzba to Typhoid-Paratyphoid Vaccines
This is a "connection" page, showing publications Thomas Wierzba has written about Typhoid-Paratyphoid Vaccines.
Connection Strength
1.099
-
Wierzba TF, Sanders JW. The global burden of enteric fevers in the age of typhoid-conjugate vaccines. Lancet Infect Dis. 2019 04; 19(4):340-341.
Score: 0.692
-
Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale VV, Ramani E, Kim YE, Park JK, Wierzba TF. Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment. Lancet Glob Health. 2014 Oct; 2(10):e570-80.
Score: 0.128
-
Bajracharya D, Khan MI, Pach A, Shrestha P, Joshi N, Upreti SR, Wierzba T, Puri M, Sahastrabuddhe S, Ochiai RL. 25 years after Vi typhoid vaccine efficacy study, typhoid affects significant number of population in Nepal. PLoS One. 2014; 9(1):e77974.
Score: 0.121
-
Kaljee LM, Pach A, Thriemer K, Ley B, Jiddawi M, Puri M, Ochiai L, Wierzba T, Clemens J, Ali SM. Desirability for a typhoid fever vaccine among rural residents, Pemba Island, Tanzania. Vaccine. 2013 Jun 24; 31(29):2994-9.
Score: 0.116
-
Jeon HJ, Pak GD, Im J, Owusu-Dabo E, Adu-Sarkodie Y, Gassama Sow A, Bassiahi Soura A, Gasmelseed N, Keddy KH, Bjerregaard-Andersen M, Konings F, Aseffa A, Crump JA, Chon Y, Breiman RF, Park SE, Cruz Espinoza LM, Seo HJ, May J, Meyer CG, Andrews JR, Panzner U, von Kalckreuth V, Wierzba TF, Rakotozandrindrainy R, Dougan G, Levine MM, Hombach J, Kim JH, Clemens JD, Baker S, Marks F. Determining the Best Immunization Strategy for Protecting African Children Against Invasive Salmonella Disease. Clin Infect Dis. 2018 11 28; 67(12):1824-1830.
Score: 0.043